Clorox Healthcare Fuzion Cleaner Disinfectant

https://www.cloroxpro.com/news-events/clorox-healthcare-fuzion-cleaner-disinfectant/ April 10, 2019
CloroxPro https://www.cloroxpro.com/wp-content/themes/electro/img/global/logo.svg

In a new study published in the American Journal of Infection Control, 24 percent of non-isolation rooms tested positive for C. diff spores and 10 percent tested positive for MRSA after standard cleaning with a quaternary ammonium disinfectant, but routine use of a novel sporicidal disinfectant significantly reduced contam-ination. Researchers from the Louis Stokes Cleveland Veterans Affairs Medical Center compared the frequency of environmental contamination in standard patient rooms that had not been used to treat patients with CDI for three-week periods before and after switching cleaning protocols from a quaternary ammonium disinfectant to Clorox Healthcare Fuzion Cleaner Disinfectant, a novel form of bleach that kills C. diff spores in two minutes, has a low odor profile and is safe to use on a wide variety of surfaces. Prior to May 1, 2018, environmental services professional at the 215-bed acute care facility used commercial bleach wipes for daily and post-discharge cleaning of CDI rooms and a quaternary ammonium disinfectant for non-CDI rooms.

Let's Stay Connected

Get Our Updates

Subscribe

Follow Us on Twitter

Follow

Get in Touch

Contact